Association for Molecular Pathology v. Myriad Genetics

Supreme Court Ruling that Human Genes May Not Be Patented

more+
less-

Full text copy of the unanimous U.S. Supreme Court ruling in Association for Molecular Pathology v. Myriad Genetics that human genes may not be patented because they occur naturally in nature.

From Greg Stohr writing for Bloomberg:

“The U.S. Supreme Court restricted the ability of companies to patent human genetic sequences, ruling in a case that tested a decades-old practice and raised questions about thousands of biotechnology, agricultural and drug patents.

The justices unanimously issued a mixed ruling on Myriad Genetics Inc.’s patents on genes linked to breast and ovarian cancer. The majority said that some parts of Myriad’s patents improperly covered natural phenomena, while other parts require enough human intervention to be eligible for legal protection.

The ruling marks an important moment for patent law, with implications for the growing field of personalized medicine and efforts to map the human brain and discover new uses for embryonic stem cells.

The decision is a partial victory for doctors’ groups and patient advocates that accused Myriad of using its patents to block clinical testing and research. Biotechnology, agriculture and drug industries backed Myriad in the case, telling the court that gene patents have led to valuable treatments.”

LOADING PDF: If there are any problems, click here to download the file.

Reference Info:Verdict | Federal, U.S. Supreme Court | United States


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© JD Supra Perspectives | Attorney Advertising

Written by:

more+
less-

JD Supra Perspectives on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×